CureVac N.V (NASDAQ:CVAC) currently has a daily average trading volume of 656.92K but it saw 835707 shares traded in last market. With a market cap of 999.69M USD, the company’s current market price of $4.44 came rising about 2.07 while comparing to the previous closing price of $4.35. In past 52 weeks, the stock remained buoying in the range of price level as high as $5.28 and as low as $2.37.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Leerink Partners which downgraded the stock as “Market Perform” in its note to investors issued on April 25, 2024, recommending a price target of between $12 and $4 for it. UBS issued its recommendations for the stock as it upgraded the price target for the stock in the range of between $8 and $18.
Over the week, CVAC’s stock price is moving 3.74% up while it is 27.95% when we observe its performance for the past one month. Year-to-date it is 30.21% up and over the past year, the stock is showing an upside performance of 11.84%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of -0.15 while estimate for next year EPS is -0.6. In next quarter, company is expected to be making quarterly sales of $4.27M as analysts are expecting the sales for current fiscal year at $59.15M and seeing the company making $85.64M in sales next year. Moreover, analysts are in estimates of $4.27M for current-quarter revenue.
Currently, CureVac N.V’s total number of outstanding shares is 225.16M with 57.44% of that held by the insiders while 4.62% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 27.75% and return on equity (ROE) at 34.46%. It has a price to earnings ratio (P/E ratio) of 4.93. Stock’s beta reads 2.49. Stock has a price to book (P/B) ratio of 1.43 while price to sale or P/S ratio amounts to 1.74. Its return on asset (ROA) is 26.30% on average.
